RE: Seems a formality now10 Apr 2023 17:17
Yes, completely and utterly moronic. They made a plan, it turns out it’s working better than they ever expected so they changed their plan. Yeah, terrible news…moron. You’re embarrassing yourself, the study design says the purpose of phase 1a is to find the MTD and or R2PD. The change of plans have accelerated determining efficacy, but I suppose it’s best to ignore that.
They’ve got plenty cash, they can postpone Dx shopping plans, they can raise again, they’ve proven getting cash isn’t an issue, the last raise was massively oversubscribed. So, what’s left miserable FUDster, timescales - that’s your problem, if you’re impatient and want to chase a binary gamble/spike elsewhere again, go for it. Those with patience are relaxed and add on dips.
Your earlier essay shows no confidence in the company. If the tech is going to be overtaken and you’ve no confidence in Alan delivering anything, get your brown crayons out again and see if you can pick another brilliant winner. Given there’s no future, then I’m sure any big pharma will manage to see the same as the resident expert sealion. Best sell before the 20p placing. Moron.